Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.21.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Current Assets:    
Cash $ 32,537,480 $ 24,782,128
Accounts receivable, net 460,131 1,373,754
Prepaid expenses and other current assets 214,744 107,651
Total Current Assets 33,212,355 26,263,533
Intangible assets, net 1,060,402 1,071,850
Property and equipment, net 17,189 17,166
Deferred offering costs 10,000 10,000
Total Assets 34,299,946 27,362,549
Current Liabilities:    
Accounts payable - suppliers 333,505 336,028
Accounts payable - trade 728,193 1,106,604
Accrued expenses and other current liabilities 351,076 1,028,307
Accrued interest 5,559 3,975
Notes payable 300,885 218,461
Total Current Liabilities 1,719,218 2,693,375
Notes payable, non-current portion 105,205 187,629
Total Liabilities 1,824,423 2,881,004
Commitments and contingencies (Note 5)
Stockholders' Equity :    
Preferred stock, $0.00001 par value; 5,000,000 shares authorized; No shares issued and outstanding as of March 31, 2021 and December 31, 2020 0  
Common stock, $0.00001 par value; 95,000,000 shares authorized; 13,873,510 and 11,756,109 shares issued and outstanding as of March 31, 2021 and December 31, 2020 139 118
Additional paid-in capital 50,561,073 40,770,504
Accumulated deficit (18,085,689) (16,289,077)
Total Stockholders' Equity 32,475,523 24,481,545
Total Liabilities and Stockholders' Equity $ 34,299,946 $ 27,362,549